Selected research
Market Outlook & Growth Opportunities
Global Absorbable Dermal Fillers Market Outlook and Growth Opportunities 2026
Market perspective
The global Absorbable Dermal Fillers market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.
The North America market for Absorbable Dermal Fillers is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Absorbable Dermal Fillers is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Absorbable Dermal Fillers is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
In China, the Absorbable Dermal Fillers market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Major global companies in the Absorbable Dermal Fillers market include Allergan Aesthetics, AQTIS Medical, Croma Pharma, Dermax, Galderma Laboratories, Hugel Aesthetics, Humedix, Imeik Technology and Laboratories Hyamed SA, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.
This report provides an overview of the global Absorbable Dermal Fillers market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Absorbable Dermal Fillers and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Absorbable Dermal Fillers revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Absorbable Dermal Fillers market.
Absorbable Dermal Fillers Segment by Company
Allergan Aesthetics
AQTIS Medical
Croma Pharma
Dermax
Galderma Laboratories
Hugel Aesthetics
Humedix
Imeik Technology
Laboratories Hyamed SA
LG Life Sciences
Medytox
Merz
Pharma Research Products
PRP Life Science
Sinclair Pharmaceuticals
Chuang'er biology
Hafod Bioscience
Haohai Biological Technology
Huadong Medicine
Bloomage BioTechnology
Shanxi Jinbo Bio-Pharmaceutical
Giant Biogene
SciVision Biotech
Monbron Bio
ReGEN Biomedical
Sunmax Biotechnology
Changchun Sinobiomaterials Co
Absorbable Dermal Fillers Segment by Type
HA
CaHA
PLLA
PCL
Collagen
Absorbable Dermal Fillers Segment by Application
Medical Beauty Institution
Plastic Surgery Hospital
Others
Absorbable Dermal Fillers Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global Absorbable Dermal Fillers status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.
2. To present the Absorbable Dermal Fillers key companies, revenue, market share, and recent developments.
3. To split the Absorbable Dermal Fillers breakdown data by regions, type, companies, and application.
4. To analyze the global and key regions Absorbable Dermal Fillers market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify Absorbable Dermal Fillers significant trends, drivers, influence factors in global and regions.
6. To analyze Absorbable Dermal Fillers competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Absorbable Dermal Fillers market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Absorbable Dermal Fillers and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Absorbable Dermal Fillers.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size.
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Absorbable Dermal Fillers industry.
Chapter 3: Detailed analysis of Absorbable Dermal Fillers company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales value of Absorbable Dermal Fillers in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.
Chapter 7: Sales value of Absorbable Dermal Fillers in country level. It provides sigmate data by type, and by application for each country/region.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 9: Concluding Insights.
More report detail
Tables and figures
Scope & coverage.
Types
- HA
- CaHA
- PLLA
- PCL
- Collagen
Applications
- Medical Beauty Institution
- Plastic Surgery Hospital
- Others
Companies covered
- Allergan Aesthetics
- AQTIS Medical
- Croma Pharma
- Dermax
- Galderma Laboratories
- Hugel Aesthetics
- Humedix
- Imeik Technology
- Laboratories Hyamed SA
- LG Life Sciences
- Medytox
- Merz
- Pharma Research Products
- PRP Life Science
- Sinclair Pharmaceuticals
- Chuang'er biology
- Hafod Bioscience
- Haohai Biological Technology
- Huadong Medicine
- Bloomage BioTechnology
- Shanxi Jinbo Bio-Pharmaceutical
- Giant Biogene
- SciVision Biotech
- Monbron Bio
- ReGEN Biomedical
- Sunmax Biotechnology
- Changchun Sinobiomaterials Co
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Absorbable Dermal Fillers Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Absorbable Dermal Fillers Market Size (2021-2032)
- 1.4 Assumptions and Limitations
- 1.5 Study Goals and Objectives
2 Absorbable Dermal Fillers Market Dynamics
- 2.1 Absorbable Dermal Fillers Industry Trends
- 2.2 Absorbable Dermal Fillers Industry Drivers
- 2.3 Absorbable Dermal Fillers Industry Opportunities and Challenges
- 2.4 Absorbable Dermal Fillers Industry Restraints
3 Absorbable Dermal Fillers Market by Company
- 3.1 Global Absorbable Dermal Fillers Company Revenue Ranking in 2025
- 3.2 Global Absorbable Dermal Fillers Revenue by Company (2021-2026)
- 3.3 Global Absorbable Dermal Fillers Company Ranking (2024-2026)
- 3.4 Global Absorbable Dermal Fillers Company Manufacturing Base and Headquarters
- 3.5 Global Absorbable Dermal Fillers Company Product Type and Application
- 3.6 Global Absorbable Dermal Fillers Company Establishment Date
- 3.7 Market Competitive Analysis
- 3.7.1 Global Absorbable Dermal Fillers Market Concentration Ratio (CR5 and HHI)
- 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
- 3.7.3 2025 Absorbable Dermal Fillers Tier 1, Tier 2, and Tier 3 Companies
- 3.8 Mergers and Acquisitions Expansion
4 Absorbable Dermal Fillers Market by Type
- 4.1 Absorbable Dermal Fillers Type Introduction
- 4.1.1 HA
- 4.1.2 CaHA
- 4.1.3 PLLA
- 4.1.4 PCL
- 4.1.5 Collagen
- 4.2 Global Absorbable Dermal Fillers Sales Value by Type
- 4.2.1 Global Absorbable Dermal Fillers Sales Value by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Absorbable Dermal Fillers Sales Value by Type (2021-2032)
- 4.2.3 Global Absorbable Dermal Fillers Sales Value Share by Type (2021-2032)
5 Absorbable Dermal Fillers Market by Application
- 5.1 Absorbable Dermal Fillers Application Introduction
- 5.1.1 Medical Beauty Institution
- 5.1.2 Plastic Surgery Hospital
- 5.1.3 Others
- 5.2 Global Absorbable Dermal Fillers Sales Value by Application
- 5.2.1 Global Absorbable Dermal Fillers Sales Value by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Absorbable Dermal Fillers Sales Value by Application (2021-2032)
- 5.2.3 Global Absorbable Dermal Fillers Sales Value Share by Application (2021-2032)
6 Absorbable Dermal Fillers Regional Value Analysis
- 6.1 Global Absorbable Dermal Fillers Sales Value by Region: 2021 VS 2025 VS 2032
- 6.2 Global Absorbable Dermal Fillers Sales Value by Region (2021-2032)
- 6.2.1 Global Absorbable Dermal Fillers Sales Value by Region: 2021-2026
- 6.2.2 Global Absorbable Dermal Fillers Sales Value by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Absorbable Dermal Fillers Sales Value (2021-2032)
- 6.3.2 North America Absorbable Dermal Fillers Sales Value Share by Country, 2025 VS 2032
- 6.4 Europe
- 6.4.1 Europe Absorbable Dermal Fillers Sales Value (2021-2032)
- 6.4.2 Europe Absorbable Dermal Fillers Sales Value Share by Country, 2025 VS 2032
- 6.5 Asia-Pacific
- 6.5.1 Asia-Pacific Absorbable Dermal Fillers Sales Value (2021-2032)
- 6.5.2 Asia-Pacific Absorbable Dermal Fillers Sales Value Share by Country, 2025 VS 2032
- 6.6 South America
- 6.6.1 South America Absorbable Dermal Fillers Sales Value (2021-2032)
- 6.6.2 South America Absorbable Dermal Fillers Sales Value Share by Country, 2025 VS 2032
- 6.7 Middle East & Africa
- 6.7.1 Middle East & Africa Absorbable Dermal Fillers Sales Value (2021-2032)
- 6.7.2 Middle East & Africa Absorbable Dermal Fillers Sales Value Share by Country, 2025 VS 2032
7 Absorbable Dermal Fillers Country-level Value Analysis
- 7.1 Global Absorbable Dermal Fillers Sales Value by Country: 2021 VS 2025 VS 2032
- 7.2 Global Absorbable Dermal Fillers Sales Value by Country (2021-2032)
- 7.2.1 Global Absorbable Dermal Fillers Sales Value by Country (2021-2026)
- 7.2.2 Global Absorbable Dermal Fillers Sales Value by Country (2027-2032)
- 7.3 USA
- 7.3.1 USA Absorbable Dermal Fillers Sales Value Growth Rate (2021-2032)
- 7.3.2 USA Absorbable Dermal Fillers Sales Value Share by Type, 2025 VS 2032
- 7.3.3 USA Absorbable Dermal Fillers Sales Value Share by Application, 2025 VS 2032
- 7.4 Canada
- 7.4.1 Canada Absorbable Dermal Fillers Sales Value Growth Rate (2021-2032)
- 7.4.2 Canada Absorbable Dermal Fillers Sales Value Share by Type, 2025 VS 2032
- 7.4.3 Canada Absorbable Dermal Fillers Sales Value Share by Application, 2025 VS 2032
- 7.5 Mexico
- 7.5.1 Mexico Absorbable Dermal Fillers Sales Value Growth Rate (2021-2032)
- 7.5.2 Mexico Absorbable Dermal Fillers Sales Value Share by Type, 2025 VS 2032
- 7.5.3 Mexico Absorbable Dermal Fillers Sales Value Share by Application, 2025 VS 2032
- 7.6 Germany
- 7.6.1 Germany Absorbable Dermal Fillers Sales Value Growth Rate (2021-2032)
- 7.6.2 Germany Absorbable Dermal Fillers Sales Value Share by Type, 2025 VS 2032
- 7.6.3 Germany Absorbable Dermal Fillers Sales Value Share by Application, 2025 VS 2032
- 7.7 France
- 7.7.1 France Absorbable Dermal Fillers Sales Value Growth Rate (2021-2032)
- 7.7.2 France Absorbable Dermal Fillers Sales Value Share by Type, 2025 VS 2032
- 7.7.3 France Absorbable Dermal Fillers Sales Value Share by Application, 2025 VS 2032
- 7.8 U.K.
- 7.8.1 U.K. Absorbable Dermal Fillers Sales Value Growth Rate (2021-2032)
- 7.8.2 U.K. Absorbable Dermal Fillers Sales Value Share by Type, 2025 VS 2032
- 7.8.3 U.K. Absorbable Dermal Fillers Sales Value Share by Application, 2025 VS 2032
- 7.9 Italy
- 7.9.1 Italy Absorbable Dermal Fillers Sales Value Growth Rate (2021-2032)
- 7.9.2 Italy Absorbable Dermal Fillers Sales Value Share by Type, 2025 VS 2032
- 7.9.3 Italy Absorbable Dermal Fillers Sales Value Share by Application, 2025 VS 2032
- 7.10 Spain
- 7.10.1 Spain Absorbable Dermal Fillers Sales Value Growth Rate (2021-2032)
- 7.10.2 Spain Absorbable Dermal Fillers Sales Value Share by Type, 2025 VS 2032
- 7.10.3 Spain Absorbable Dermal Fillers Sales Value Share by Application, 2025 VS 2032
- 7.11 Russia
- 7.11.1 Russia Absorbable Dermal Fillers Sales Value Growth Rate (2021-2032)
- 7.11.2 Russia Absorbable Dermal Fillers Sales Value Share by Type, 2025 VS 2032
- 7.11.3 Russia Absorbable Dermal Fillers Sales Value Share by Application, 2025 VS 2032
- 7.12 Netherlands
- 7.12.1 Netherlands Absorbable Dermal Fillers Sales Value Growth Rate (2021-2032)
- 7.12.2 Netherlands Absorbable Dermal Fillers Sales Value Share by Type, 2025 VS 2032
- 7.12.3 Netherlands Absorbable Dermal Fillers Sales Value Share by Application, 2025 VS 2032
- 7.13 Nordic Countries
- 7.13.1 Nordic Countries Absorbable Dermal Fillers Sales Value Growth Rate (2021-2032)
- 7.13.2 Nordic Countries Absorbable Dermal Fillers Sales Value Share by Type, 2025 VS 2032
- 7.13.3 Nordic Countries Absorbable Dermal Fillers Sales Value Share by Application, 2025 VS 2032
- 7.14 China
- 7.14.1 China Absorbable Dermal Fillers Sales Value Growth Rate (2021-2032)
- 7.14.2 China Absorbable Dermal Fillers Sales Value Share by Type, 2025 VS 2032
- 7.14.3 China Absorbable Dermal Fillers Sales Value Share by Application, 2025 VS 2032
- 7.15 Japan
- 7.15.1 Japan Absorbable Dermal Fillers Sales Value Growth Rate (2021-2032)
- 7.15.2 Japan Absorbable Dermal Fillers Sales Value Share by Type, 2025 VS 2032
- 7.15.3 Japan Absorbable Dermal Fillers Sales Value Share by Application, 2025 VS 2032
- 7.16 South Korea
- 7.16.1 South Korea Absorbable Dermal Fillers Sales Value Growth Rate (2021-2032)
- 7.16.2 South Korea Absorbable Dermal Fillers Sales Value Share by Type, 2025 VS 2032
- 7.16.3 South Korea Absorbable Dermal Fillers Sales Value Share by Application, 2025 VS 2032
- 7.17 India
- 7.17.1 India Absorbable Dermal Fillers Sales Value Growth Rate (2021-2032)
- 7.17.2 India Absorbable Dermal Fillers Sales Value Share by Type, 2025 VS 2032
- 7.17.3 India Absorbable Dermal Fillers Sales Value Share by Application, 2025 VS 2032
- 7.18 Australia
- 7.18.1 Australia Absorbable Dermal Fillers Sales Value Growth Rate (2021-2032)
- 7.18.2 Australia Absorbable Dermal Fillers Sales Value Share by Type, 2025 VS 2032
- 7.18.3 Australia Absorbable Dermal Fillers Sales Value Share by Application, 2025 VS 2032
- 7.19 Southeast Asia
- 7.19.1 Southeast Asia Absorbable Dermal Fillers Sales Value Growth Rate (2021-2032)
- 7.19.2 Southeast Asia Absorbable Dermal Fillers Sales Value Share by Type, 2025 VS 2032
- 7.19.3 Southeast Asia Absorbable Dermal Fillers Sales Value Share by Application, 2025 VS 2032
- 7.20 Brazil
- 7.20.1 Brazil Absorbable Dermal Fillers Sales Value Growth Rate (2021-2032)
- 7.20.2 Brazil Absorbable Dermal Fillers Sales Value Share by Type, 2025 VS 2032
- 7.20.3 Brazil Absorbable Dermal Fillers Sales Value Share by Application, 2025 VS 2032
- 7.21 Argentina
- 7.21.1 Argentina Absorbable Dermal Fillers Sales Value Growth Rate (2021-2032)
- 7.21.2 Argentina Absorbable Dermal Fillers Sales Value Share by Type, 2025 VS 2032
- 7.21.3 Argentina Absorbable Dermal Fillers Sales Value Share by Application, 2025 VS 2032
- 7.22 Chile
- 7.22.1 Chile Absorbable Dermal Fillers Sales Value Growth Rate (2021-2032)
- 7.22.2 Chile Absorbable Dermal Fillers Sales Value Share by Type, 2025 VS 2032
- 7.22.3 Chile Absorbable Dermal Fillers Sales Value Share by Application, 2025 VS 2032
- 7.23 Colombia
- 7.23.1 Colombia Absorbable Dermal Fillers Sales Value Growth Rate (2021-2032)
- 7.23.2 Colombia Absorbable Dermal Fillers Sales Value Share by Type, 2025 VS 2032
- 7.23.3 Colombia Absorbable Dermal Fillers Sales Value Share by Application, 2025 VS 2032
- 7.24 Peru
- 7.24.1 Peru Absorbable Dermal Fillers Sales Value Growth Rate (2021-2032)
- 7.24.2 Peru Absorbable Dermal Fillers Sales Value Share by Type, 2025 VS 2032
- 7.24.3 Peru Absorbable Dermal Fillers Sales Value Share by Application, 2025 VS 2032
- 7.25 Saudi Arabia
- 7.25.1 Saudi Arabia Absorbable Dermal Fillers Sales Value Growth Rate (2021-2032)
- 7.25.2 Saudi Arabia Absorbable Dermal Fillers Sales Value Share by Type, 2025 VS 2032
- 7.25.3 Saudi Arabia Absorbable Dermal Fillers Sales Value Share by Application, 2025 VS 2032
- 7.26 Israel
- 7.26.1 Israel Absorbable Dermal Fillers Sales Value Growth Rate (2021-2032)
- 7.26.2 Israel Absorbable Dermal Fillers Sales Value Share by Type, 2025 VS 2032
- 7.26.3 Israel Absorbable Dermal Fillers Sales Value Share by Application, 2025 VS 2032
- 7.27 UAE
- 7.27.1 UAE Absorbable Dermal Fillers Sales Value Growth Rate (2021-2032)
- 7.27.2 UAE Absorbable Dermal Fillers Sales Value Share by Type, 2025 VS 2032
- 7.27.3 UAE Absorbable Dermal Fillers Sales Value Share by Application, 2025 VS 2032
- 7.28 Turkey
- 7.28.1 Turkey Absorbable Dermal Fillers Sales Value Growth Rate (2021-2032)
- 7.28.2 Turkey Absorbable Dermal Fillers Sales Value Share by Type, 2025 VS 2032
- 7.28.3 Turkey Absorbable Dermal Fillers Sales Value Share by Application, 2025 VS 2032
- 7.29 Iran
- 7.29.1 Iran Absorbable Dermal Fillers Sales Value Growth Rate (2021-2032)
- 7.29.2 Iran Absorbable Dermal Fillers Sales Value Share by Type, 2025 VS 2032
- 7.29.3 Iran Absorbable Dermal Fillers Sales Value Share by Application, 2025 VS 2032
- 7.30 Egypt
- 7.30.1 Egypt Absorbable Dermal Fillers Sales Value Growth Rate (2021-2032)
- 7.30.2 Egypt Absorbable Dermal Fillers Sales Value Share by Type, 2025 VS 2032
- 7.30.3 Egypt Absorbable Dermal Fillers Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
- 8.1 Allergan Aesthetics
- 8.1.1 Allergan Aesthetics Company Information
- 8.1.2 Allergan Aesthetics Business Overview
- 8.1.3 Allergan Aesthetics Absorbable Dermal Fillers Revenue and Gross Margin (2021-2026)
- 8.1.4 Allergan Aesthetics Absorbable Dermal Fillers Product Portfolio
- 8.1.5 Allergan Aesthetics Recent Developments
- 8.2 AQTIS Medical
- 8.2.1 AQTIS Medical Company Information
- 8.2.2 AQTIS Medical Business Overview
- 8.2.3 AQTIS Medical Absorbable Dermal Fillers Revenue and Gross Margin (2021-2026)
- 8.2.4 AQTIS Medical Absorbable Dermal Fillers Product Portfolio
- 8.2.5 AQTIS Medical Recent Developments
- 8.3 Croma Pharma
- 8.3.1 Croma Pharma Company Information
- 8.3.2 Croma Pharma Business Overview
- 8.3.3 Croma Pharma Absorbable Dermal Fillers Revenue and Gross Margin (2021-2026)
- 8.3.4 Croma Pharma Absorbable Dermal Fillers Product Portfolio
- 8.3.5 Croma Pharma Recent Developments
- 8.4 Dermax
- 8.4.1 Dermax Company Information
- 8.4.2 Dermax Business Overview
- 8.4.3 Dermax Absorbable Dermal Fillers Revenue and Gross Margin (2021-2026)
- 8.4.4 Dermax Absorbable Dermal Fillers Product Portfolio
- 8.4.5 Dermax Recent Developments
- 8.5 Galderma Laboratories
- 8.5.1 Galderma Laboratories Company Information
- 8.5.2 Galderma Laboratories Business Overview
- 8.5.3 Galderma Laboratories Absorbable Dermal Fillers Revenue and Gross Margin (2021-2026)
- 8.5.4 Galderma Laboratories Absorbable Dermal Fillers Product Portfolio
- 8.5.5 Galderma Laboratories Recent Developments
- 8.6 Hugel Aesthetics
- 8.6.1 Hugel Aesthetics Company Information
- 8.6.2 Hugel Aesthetics Business Overview
- 8.6.3 Hugel Aesthetics Absorbable Dermal Fillers Revenue and Gross Margin (2021-2026)
- 8.6.4 Hugel Aesthetics Absorbable Dermal Fillers Product Portfolio
- 8.6.5 Hugel Aesthetics Recent Developments
- 8.7 Humedix
- 8.7.1 Humedix Company Information
- 8.7.2 Humedix Business Overview
- 8.7.3 Humedix Absorbable Dermal Fillers Revenue and Gross Margin (2021-2026)
- 8.7.4 Humedix Absorbable Dermal Fillers Product Portfolio
- 8.7.5 Humedix Recent Developments
- 8.8 Imeik Technology
- 8.8.1 Imeik Technology Company Information
- 8.8.2 Imeik Technology Business Overview
- 8.8.3 Imeik Technology Absorbable Dermal Fillers Revenue and Gross Margin (2021-2026)
- 8.8.4 Imeik Technology Absorbable Dermal Fillers Product Portfolio
- 8.8.5 Imeik Technology Recent Developments
- 8.9 Laboratories Hyamed SA
- 8.9.1 Laboratories Hyamed SA Company Information
- 8.9.2 Laboratories Hyamed SA Business Overview
- 8.9.3 Laboratories Hyamed SA Absorbable Dermal Fillers Revenue and Gross Margin (2021-2026)
- 8.9.4 Laboratories Hyamed SA Absorbable Dermal Fillers Product Portfolio
- 8.9.5 Laboratories Hyamed SA Recent Developments
- 8.10 LG Life Sciences
- 8.10.1 LG Life Sciences Company Information
- 8.10.2 LG Life Sciences Business Overview
- 8.10.3 LG Life Sciences Absorbable Dermal Fillers Revenue and Gross Margin (2021-2026)
- 8.10.4 LG Life Sciences Absorbable Dermal Fillers Product Portfolio
- 8.10.5 LG Life Sciences Recent Developments
- 8.11 Medytox
- 8.11.1 Medytox Company Information
- 8.11.2 Medytox Business Overview
- 8.11.3 Medytox Absorbable Dermal Fillers Revenue and Gross Margin (2021-2026)
- 8.11.4 Medytox Absorbable Dermal Fillers Product Portfolio
- 8.11.5 Medytox Recent Developments
- 8.12 Merz
- 8.12.1 Merz Company Information
- 8.12.2 Merz Business Overview
- 8.12.3 Merz Absorbable Dermal Fillers Revenue and Gross Margin (2021-2026)
- 8.12.4 Merz Absorbable Dermal Fillers Product Portfolio
- 8.12.5 Merz Recent Developments
- 8.13 Pharma Research Products
- 8.13.1 Pharma Research Products Company Information
- 8.13.2 Pharma Research Products Business Overview
- 8.13.3 Pharma Research Products Absorbable Dermal Fillers Revenue and Gross Margin (2021-2026)
- 8.13.4 Pharma Research Products Absorbable Dermal Fillers Product Portfolio
- 8.13.5 Pharma Research Products Recent Developments
- 8.14 PRP Life Science
- 8.14.1 PRP Life Science Company Information
- 8.14.2 PRP Life Science Business Overview
- 8.14.3 PRP Life Science Absorbable Dermal Fillers Revenue and Gross Margin (2021-2026)
- 8.14.4 PRP Life Science Absorbable Dermal Fillers Product Portfolio
- 8.14.5 PRP Life Science Recent Developments
- 8.15 Sinclair Pharmaceuticals
- 8.15.1 Sinclair Pharmaceuticals Company Information
- 8.15.2 Sinclair Pharmaceuticals Business Overview
- 8.15.3 Sinclair Pharmaceuticals Absorbable Dermal Fillers Revenue and Gross Margin (2021-2026)
- 8.15.4 Sinclair Pharmaceuticals Absorbable Dermal Fillers Product Portfolio
- 8.15.5 Sinclair Pharmaceuticals Recent Developments
- 8.16 Chuang'er biology
- 8.16.1 Chuang'er biology Company Information
- 8.16.2 Chuang'er biology Business Overview
- 8.16.3 Chuang'er biology Absorbable Dermal Fillers Revenue and Gross Margin (2021-2026)
- 8.16.4 Chuang'er biology Absorbable Dermal Fillers Product Portfolio
- 8.16.5 Chuang'er biology Recent Developments
- 8.17 Hafod Bioscience
- 8.17.1 Hafod Bioscience Company Information
- 8.17.2 Hafod Bioscience Business Overview
- 8.17.3 Hafod Bioscience Absorbable Dermal Fillers Revenue and Gross Margin (2021-2026)
- 8.17.4 Hafod Bioscience Absorbable Dermal Fillers Product Portfolio
- 8.17.5 Hafod Bioscience Recent Developments
- 8.18 Haohai Biological Technology
- 8.18.1 Haohai Biological Technology Company Information
- 8.18.2 Haohai Biological Technology Business Overview
- 8.18.3 Haohai Biological Technology Absorbable Dermal Fillers Revenue and Gross Margin (2021-2026)
- 8.18.4 Haohai Biological Technology Absorbable Dermal Fillers Product Portfolio
- 8.18.5 Haohai Biological Technology Recent Developments
- 8.19 Huadong Medicine
- 8.19.1 Huadong Medicine Company Information
- 8.19.2 Huadong Medicine Business Overview
- 8.19.3 Huadong Medicine Absorbable Dermal Fillers Revenue and Gross Margin (2021-2026)
- 8.19.4 Huadong Medicine Absorbable Dermal Fillers Product Portfolio
- 8.19.5 Huadong Medicine Recent Developments
- 8.20 Bloomage BioTechnology
- 8.20.1 Bloomage BioTechnology Company Information
- 8.20.2 Bloomage BioTechnology Business Overview
- 8.20.3 Bloomage BioTechnology Absorbable Dermal Fillers Revenue and Gross Margin (2021-2026)
- 8.20.4 Bloomage BioTechnology Absorbable Dermal Fillers Product Portfolio
- 8.20.5 Bloomage BioTechnology Recent Developments
- 8.21 Shanxi Jinbo Bio-Pharmaceutical
- 8.21.1 Shanxi Jinbo Bio-Pharmaceutical Company Information
- 8.21.2 Shanxi Jinbo Bio-Pharmaceutical Business Overview
- 8.21.3 Shanxi Jinbo Bio-Pharmaceutical Absorbable Dermal Fillers Revenue and Gross Margin (2021-2026)
- 8.21.4 Shanxi Jinbo Bio-Pharmaceutical Absorbable Dermal Fillers Product Portfolio
- 8.21.5 Shanxi Jinbo Bio-Pharmaceutical Recent Developments
- 8.22 Giant Biogene
- 8.22.1 Giant Biogene Company Information
- 8.22.2 Giant Biogene Business Overview
- 8.22.3 Giant Biogene Absorbable Dermal Fillers Revenue and Gross Margin (2021-2026)
- 8.22.4 Giant Biogene Absorbable Dermal Fillers Product Portfolio
- 8.22.5 Giant Biogene Recent Developments
- 8.23 SciVision Biotech
- 8.23.1 SciVision Biotech Company Information
- 8.23.2 SciVision Biotech Business Overview
- 8.23.3 SciVision Biotech Absorbable Dermal Fillers Revenue and Gross Margin (2021-2026)
- 8.23.4 SciVision Biotech Absorbable Dermal Fillers Product Portfolio
- 8.23.5 SciVision Biotech Recent Developments
- 8.24 Monbron Bio
- 8.24.1 Monbron Bio Company Information
- 8.24.2 Monbron Bio Business Overview
- 8.24.3 Monbron Bio Absorbable Dermal Fillers Revenue and Gross Margin (2021-2026)
- 8.24.4 Monbron Bio Absorbable Dermal Fillers Product Portfolio
- 8.24.5 Monbron Bio Recent Developments
- 8.25 ReGEN Biomedical
- 8.25.1 ReGEN Biomedical Company Information
- 8.25.2 ReGEN Biomedical Business Overview
- 8.25.3 ReGEN Biomedical Absorbable Dermal Fillers Revenue and Gross Margin (2021-2026)
- 8.25.4 ReGEN Biomedical Absorbable Dermal Fillers Product Portfolio
- 8.25.5 ReGEN Biomedical Recent Developments
- 8.26 Sunmax Biotechnology
- 8.26.1 Sunmax Biotechnology Company Information
- 8.26.2 Sunmax Biotechnology Business Overview
- 8.26.3 Sunmax Biotechnology Absorbable Dermal Fillers Revenue and Gross Margin (2021-2026)
- 8.26.4 Sunmax Biotechnology Absorbable Dermal Fillers Product Portfolio
- 8.26.5 Sunmax Biotechnology Recent Developments
- 8.27 Changchun Sinobiomaterials Co
- 8.27.1 Changchun Sinobiomaterials Co Company Information
- 8.27.2 Changchun Sinobiomaterials Co Business Overview
- 8.27.3 Changchun Sinobiomaterials Co Absorbable Dermal Fillers Revenue and Gross Margin (2021-2026)
- 8.27.4 Changchun Sinobiomaterials Co Absorbable Dermal Fillers Product Portfolio
- 8.27.5 Changchun Sinobiomaterials Co Recent Developments
9 Concluding Insights
10 Appendix
- 10.1 Reasons for Doing This Study
- 10.2 Research Methodology
- 10.3 Research Process
- 10.4 Authors List of This Report
- 10.5 Data Source
- 10.5.1 Secondary Sources
- 10.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst